| 1 | Computer-Based Image Analysis for Plus Disease Diagnosis in… (10.1167/tvst.4.6.5) | Abstract References ORCID License | 209.69 | 124 |
| 2 | Topical, Aqueous, Clear Cyclosporine Formulation Design for… (10.1167/tvst.4.3.1) | Abstract References ORCID License | 193.95 | 86 |
| 3 | Quantitative Analysis of Mouse Retinal Layers Using Automate… (10.1167/tvst.4.4.9) | Abstract References ORCID License | 189.76 | 78 |
| 4 | Topical Ocular Drug Delivery to the Back of the Eye by Mucus… (10.1167/tvst.4.3.11) | Abstract References ORCID License | 188.65 | 76 |
| 5 | Natural Bioadhesive Biodegradable Nanoparticle-Based Topical… (10.1167/tvst.4.3.12) | Abstract References ORCID License | 187.51 | 74 |
| 6 | VFMA: Topographic Analysis of Sensitivity Data From Full-Fie… (10.1167/tvst.4.2.14) | Abstract References ORCID License | 177.09 | 58 |
| 7 | The Biomechanical Effect of Corneal Collagen Cross-Linking (… (10.1167/tvst.2.7.6) | Abstract ORCID License | 176.12 | 222 |
| 8 | Central Glaucomatous Damage of the Macula Can Be Overlooked… (10.1167/tvst.4.6.4) | Abstract References ORCID License | 173.24 | 53 |
| 9 | Effect of Signal Intensity on Measurement of Ganglion Cell C… (10.1167/tvst.4.5.7) | Abstract References ORCID License | 169.02 | 48 |
| 10 | Effects of Detergent-Based Protocols on Decellularization of… (10.1167/tvst.4.2.13) | Abstract References ORCID License | 168.12 | 47 |
| 11 | Why Do People (Still) Go Blind from Glaucoma? (10.1167/tvst.4.2.1) | Abstract ORCID License | 167.47 | 170 |
| 12 | Optimizing the Anti-VEGF Treatment Strategy for Neovascular… (10.1167/tvst.4.3.6) | Abstract References ORCID License | 165.32 | 44 |
| 13 | Automated Analysis of Vitreous Inflammation Using Spectral-D… (10.1167/tvst.4.5.4) | Abstract References ORCID License | 165.32 | 44 |
| 14 | High Tech Aids Low Vision: A Review of Image Processing for… (10.1167/tvst.4.4.6) | Abstract References ORCID License | 160.21 | 39 |
| 15 | Assessing the Accuracy of Foveal Avascular Zone Measurements… (10.1167/tvst.6.3.16) | Abstract References ORCID | 158.04 | 127 |
| 16 | The 24-2 Visual Field Test Misses Central Macular Damage Con… (10.1167/tvst.5.2.15) | Abstract References ORCID | 157.01 | 123 |
| 17 | Transcorneal Electrical Stimulation Inhibits Retinal Microgl… (10.1167/tvst.7.3.7) | Abstract References ORCID License | 155.63 | 35 |
| 18 | Terpinen-4-ol is the Most Active Ingredient of Tea Tree Oil… (10.1167/tvst.2.7.2) | Abstract ORCID License | 155.39 | 117 |
| 19 | Choroidal Vascularity Index in Vogt-Koyanagi-Harada Disease:… (10.1167/tvst.5.4.7) | Abstract References ORCID | 154.83 | 115 |
| 20 | Factors Affecting Perceptual Threshold in Argus II Retinal P… (10.1167/tvst.2.4.1) | Abstract ORCID License | 154.55 | 114 |
| 21 | Injectable Chemically Crosslinked Hydrogel for the Controlle… (10.1167/tvst.4.2.5) | Abstract ORCID License | 154.27 | 113 |
| 22 | A Comparison of Perimetric Results from a Tablet Perimeter a… (10.1167/tvst.5.6.2) | Abstract References ORCID | 152.51 | 107 |
| 23 | The Nature of Macular Damage in Glaucoma as Revealed by Aver… (10.1167/tvst.1.1.3) | Abstract ORCID License | 151.28 | 103 |
| 24 | Effect of Two Novel Sustained-Release Drug Delivery Systems… (10.1167/tvst.4.3.4) | Abstract References ORCID License | 150.51 | 31 |
| 25 | Tunnel Vision Prismatic Field Expansion: Challenges and Requ… (10.1167/tvst.4.6.8) | Abstract References ORCID License | 150.51 | 31 |
| 26 | VEGF and Intraocular Neovascularization: From Discovery to T… (10.1167/tvst.5.2.10) | Abstract References ORCID | 150.00 | 99 |
| 27 | Intrasurgical Human Retinal Imaging With Manual Instrument T… (10.1167/tvst.4.4.1) | Abstract References ORCID License | 149.14 | 30 |
| 28 | Transplantation of Human Embryonic Stem Cell-Derived Retinal… (10.1167/tvst.6.3.4) | Abstract References ORCID | 146.57 | 89 |
| 29 | Oral Mineralocorticoid-Receptor Antagonists: Real-Life Exper… (10.1167/tvst.5.2.2) | Abstract References ORCID | 145.09 | 85 |
| 30 | Validation of a Tablet as a Tangent Perimeter (10.1167/tvst.5.4.3) | Abstract References ORCID | 142.32 | 78 |
| 31 | Suprachoroidal Corticosteroid Administration: A Novel Route… (10.1167/tvst.5.6.14) | Abstract References ORCID | 141.91 | 77 |
| 32 | Reliability of VEP Recordings Using Chronically Implanted Sc… (10.1167/tvst.4.2.15) | Abstract References ORCID License | 141.50 | 25 |
| 33 | Relationship Between Motor Vehicle Collisions and Results of… (10.1167/tvst.4.3.5) | Abstract References ORCID License | 141.50 | 25 |
| 34 | Towards Standardization of Quantitative Retinal Vascular Par… (10.1167/tvst.7.2.12) | Abstract References ORCID | 139.30 | 71 |
| 35 | An Automated Reference Frame Selection (ARFS) Algorithm for… (10.1167/tvst.6.2.9) | Abstract References ORCID | 138.38 | 69 |
| 36 | Measurement of Retinal Sensitivity on Tablet Devices in Age-… (10.1167/tvst.4.3.13) | Abstract References ORCID License | 138.02 | 23 |
| 37 | Feasibility of Structural and Functional MRI Acquisition wit… (10.1167/tvst.4.6.6) | Abstract References ORCID License | 138.02 | 23 |
| 38 | A Single Wide-Field OCT Protocol Can Provide Compelling Info… (10.1167/tvst.5.6.4) | Abstract References ORCID | 136.96 | 66 |
| 39 | New Methods for Quantification of Visual Photosensitivity Th… (10.1167/tvst.6.4.18) | Abstract References ORCID | 136.96 | 66 |
| 40 | Implantable MicroPump for Drug Delivery in Patients with Dia… (10.1167/tvst.3.6.5) | Abstract ORCID License | 136.47 | 65 |
| 41 | Rodent Hyperglycemia-Induced Inner Retinal Deficits are Mirr… (10.1167/tvst.3.3.6) | Abstract ORCID License | 135.46 | 63 |
| 42 | Efficacy and Complications of Intravitreal Rituximab Injecti… (10.1167/tvst.1.3.1) | Abstract ORCID License | 134.43 | 61 |
| 43 | Simulations of Porcine Eye Exposure to Primary Blast Insult (10.1167/tvst.4.4.8) | Abstract References ORCID License | 134.24 | 21 |
| 44 | Unsupervised Gaussian Mixture-Model With Expectation Maximiz… (10.1167/tvst.5.3.2) | Abstract References ORCID | 133.36 | 59 |
| 45 | Confocal Adaptive Optics Imaging of Peripapillary Nerve Fibe… (10.1167/tvst.4.2.12) | Abstract References ORCID License | 132.22 | 20 |
| 46 | Conjunctivally Applied BDNF Protects Photoreceptors from Lig… (10.1167/tvst.4.6.1) | Abstract References ORCID License | 132.22 | 20 |
| 47 | Development of the FitSight Fitness Tracker to Increase Time… (10.1167/tvst.6.3.20) | Abstract References ORCID | 131.69 | 56 |
| 48 | Cathelicidin LL-37 and HSV-1 Corneal Infection: Peptide Vers… (10.1167/tvst.3.3.4) | Abstract ORCID License | 130.53 | 54 |
| 49 | Reference Clinical Database for Fixation Stability Metrics i… (10.1167/tvst.5.6.6) | Abstract References ORCID | 130.53 | 54 |
| 50 | Towards Treatment of Stargardt Disease: Workshop Organized a… (10.1167/tvst.6.5.6) | Abstract References ORCID | 130.53 | 54 |